Doctoral School of Medical University of Bialystok, Department of Cardiology and Internal Medicine with Cardiac Intensive Care Unit, University Clinical Hospital in Bialystok, Poland.
Student Research Group, Department of Otolaryngology, Medical University of Bialystok, Poland.
Otolaryngol Pol. 2024 Oct 31;78(5):10-17. doi: 10.5604/01.3001.0054.6742.
<b>Introduction:</b> Obstructive sleep apnea (OSA) is a chronic inflammatory disorder characterized by episodes of total or partial upper airway obstruction during sleep. Untreated OSA leads to various cardiovascular complications, including heart failure (HF), both involving complex and detrimental pathophysiological processes.<b>Aim:</b> The aim of this study is to describe the role of rostral fluid shifts and other mechanisms responsible for the co-existence of OSA and HF, providing insight into potential diagnostic and therapeutic strategies.<b>Materials and methods:</b> Two authors independently searched the literature and assessed articles following PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analytics) guidelines.<b>Results:</b> Rostral fluid shifts, characterized by nocturnal redistribution from the lower limbs to the neck tissues, exacerbate upper airway obstruction by increasing neck circumference and predisposing individuals to respiratory events. This phenomenon is particularly significant in patients with HF due to impaired cardiovascular function leading to fluid retention. The repetitive collapse of the upper airway during sleep triggers abrupt changes in intrathoracic pressure negatively impacting cardiac tissue remodeling by promoting inflammation and fibrosis. Moreover, sleep fragmentation and arousals activate the sympathetic nervous system (SNS), imposing additional strain on the cardiovascular system. Accumulated data suggest that rostral fluid shifts are a clinically significant pathomechanism in the coexistence of OSA and HF. Therapeutic strategies, including the benefits of continuous positive airway pressure (CPAP) therapy and lifestyle modifications, have been discussed. This systematic review highlights the need for integrated treatment approaches to manage both OSA and HF effectively.<b>Conclusions:</b> Understanding and addressing these interconnected mechanisms is essential to offer an integrated diagnostic and therapeutic management of patients, highlighting the importance of multidisciplinary care to optimize patient health and quality of life.
<b>引言:</b>阻塞性睡眠呼吸暂停(OSA)是一种慢性炎症性疾病,其特征是睡眠期间上呼吸道完全或部分阻塞。未经治疗的 OSA 会导致各种心血管并发症,包括心力衰竭(HF),两者都涉及复杂且有害的病理生理过程。<b>目的:</b>本研究旨在描述导致 OSA 和 HF 共存的颅液移位和其他机制的作用,为潜在的诊断和治疗策略提供深入了解。<b>材料和方法:</b>两位作者独立搜索文献,并按照 PRISMA(系统评价和荟萃分析的首选报告项目)指南评估文章。<b>结果:</b>颅液移位是指夜间从下肢向颈部组织重新分布,通过增加颈部周长使上呼吸道阻塞恶化,并使个体易患呼吸事件。由于心血管功能受损导致液体潴留,HF 患者中这种现象更为显著。睡眠期间上呼吸道反复塌陷会导致胸腔内压力突然变化,通过促进炎症和纤维化对心脏组织重塑产生负面影响。此外,睡眠片段化和觉醒会激活交感神经系统(SNS),通过对心血管系统施加额外的压力。积累的数据表明,颅液移位是 OSA 和 HF 共存的一个具有临床意义的病理机制。已经讨论了治疗策略,包括持续气道正压通气(CPAP)治疗和生活方式改变的益处。本系统评价强调了需要采用综合治疗方法来有效管理 OSA 和 HF。<b>结论:</b>理解和解决这些相互关联的机制对于提供患者综合诊断和治疗管理至关重要,突出了多学科护理的重要性,以优化患者的健康和生活质量。